RELMADA THERAPEUTICS, INC. - COM (RLMD)

Historical Portfolio Holders from Q4 2019 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
14.2 M
Holdings value Q1 2024
$65.9 M
Value change Q1 2024
+$4.42 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
88
Number of buys Q1 2024
38
Number of sells Q1 2024
-32
Average buys Q1 2024 %
+0%
Average sells Q1 2024 %
0%
CUSIP
75955J402
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 14.2 M $65.9 M +$4.42 M $4.65 88
2023 Q4 13.5 M $55.9 M -$3.18 M $4.14 80
2023 Q3 14.9 M $44.8 M -$3.17 M $3.00 85
2023 Q2 16.1 M $39.6 M -$4.05 M $2.46 90
2023 Q1 17.8 M $40.1 M -$4.35 M $2.26 86
2022 Q4 19 M $66.5 M -$456 M $3.49 107
2022 Q3 25.5 M $945 M +$76.7 M $37.02 136
2022 Q2 23.2 M $440 M +$33.7 M $18.99 108
2022 Q1 22.6 M $608 M +$64.1 M $26.99 108
2021 Q4 20.7 M $467 M +$239 M $22.53 88
2021 Q3 9.87 M $259 M -$4.61 M $26.21 80
2021 Q2 9.78 M $313 M +$11.9 M $32.01 81
2021 Q1 9.35 M $329 M +$11.9 M $35.21 76
2020 Q4 9.04 M $290 M -$48.4 M $32.07 77
2020 Q3 10.2 M $383 M -$2.36 M $37.62 71
2020 Q2 10.5 M $469 M +$57.8 M $44.75 74
2020 Q1 9.36 M $319 M +$94.7 M $34.11 40
2019 Q4 6.8 M $265 M +$214 M $39.00 44